Exact Mass: 495.28320260000004
Exact Mass Matches: 495.28320260000004
Found 205 metabolites which its exact mass value is equals to given mass value 495.28320260000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Mibefradil
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
JI-20B
C20H41N5O9 (495.2904136000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,4R,5S,6R)-3-amino-6-[(1S)-1-aminoethyl]-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3,5-diol
C20H41N5O9 (495.2904136000001)
Mibefradil
20-Ethyl-1,7,8-trihydroxy-6,16-dimethoxy-4-(methoxymethyl)aconitan-14-yl acetate #
C26H41NO8 (495.28320260000004)
6-O-Acetyl-14-O-methyldelphinifoline
C26H41NO8 (495.28320260000004)
(1alpha,6beta,14alpha,16beta)-4-[(acetyloxy)methyl]-20-ethyl-6,14,16-trimethoxyaconitane-1,7,8-triol|1-O-demethyltricornine
C26H41NO8 (495.28320260000004)
Ala His Ile Arg
Ala His Leu Arg
Ala His Arg Ile
Ala His Arg Leu
Ala Ile His Arg
Ala Ile Arg His
Ala Leu His Arg
Ala Leu Arg His
Ala Arg His Ile
Ala Arg His Leu
Ala Arg Ile His
Ala Arg Leu His
His Ala Ile Arg
His Ala Leu Arg
His Ala Arg Ile
His Ala Arg Leu
His Ile Ala Arg
His Ile Ile Asn
His Ile Leu Asn
His Ile Asn Ile
His Ile Asn Leu
His Ile Gln Val
His Ile Arg Ala
His Ile Val Gln
His Leu Ala Arg
His Leu Ile Asn
His Leu Leu Asn
His Leu Asn Ile
His Leu Asn Leu
His Leu Gln Val
His Leu Arg Ala
His Leu Val Gln
His Asn Ile Ile
His Asn Ile Leu
His Asn Leu Ile
His Asn Leu Leu
His Gln Ile Val
His Gln Leu Val
His Gln Val Ile
His Gln Val Leu
His Arg Ala Ile
His Arg Ala Leu
His Arg Ile Ala
His Arg Leu Ala
His Val Ile Gln
His Val Leu Gln
His Val Gln Ile
His Val Gln Leu
Ile Ala His Arg
Ile Ala Arg His
Ile His Ala Arg
Ile His Ile Asn
Ile His Leu Asn
Ile His Asn Ile
Ile His Asn Leu
Ile His Gln Val
Ile His Arg Ala
Ile His Val Gln
Ile Ile His Asn
Ile Ile Asn His
Ile Leu His Asn
Ile Leu Asn His
Ile Asn His Ile
Ile Asn His Leu
Ile Asn Ile His
Ile Asn Leu His
Ile Gln His Val
Ile Gln Val His
Ile Arg Ala His
Ile Arg His Ala
Ile Val His Gln
Ile Val Gln His
Leu Ala His Arg
Leu Ala Arg His
Leu His Ala Arg
Leu His Ile Asn
Leu His Leu Asn
Leu His Asn Ile
Leu His Asn Leu
Leu His Gln Val
Leu His Arg Ala
Leu His Val Gln
Leu Ile His Asn
Leu Ile Asn His
Leu Leu His Asn
Leu Leu Asn His
Leu Asn His Ile
Leu Asn His Leu
Leu Asn Ile His
Leu Asn Leu His
Leu Gln His Val
Leu Gln Val His
Leu Arg Ala His
Leu Arg His Ala
Leu Val His Gln
Leu Val Gln His
Asn His Ile Ile
Asn His Ile Leu
Asn His Leu Ile
Asn His Leu Leu
Asn Ile His Ile
Asn Ile His Leu
Asn Ile Ile His
Asn Ile Leu His
Asn Leu His Ile
Asn Leu His Leu
Asn Leu Ile His
Asn Leu Leu His
Gln His Ile Val
Gln His Leu Val
Gln His Val Ile
Gln His Val Leu
Gln Ile His Val
Gln Ile Val His
Gln Leu His Val
Gln Leu Val His
Gln Val His Ile
Gln Val His Leu
Gln Val Ile His
Gln Val Leu His
Arg Ala His Ile
Arg Ala His Leu
Arg Ala Ile His
Arg Ala Leu His
Arg His Ala Ile
Arg His Ala Leu
Arg His Ile Ala
Arg His Leu Ala
Arg Ile Ala His
Arg Ile His Ala
Arg Leu Ala His
Arg Leu His Ala
Val His Ile Gln
Val His Leu Gln
Val His Gln Ile
Val His Gln Leu
Val Ile His Gln
Val Ile Gln His
Val Leu His Gln
Val Leu Gln His
Val Gln His Ile
Val Gln His Leu
Val Gln Ile His
Val Gln Leu His
9-Phenyl-3,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
C30H35B2NO4 (495.2752050000001)
Octanoic acid, 8-oxo-8-(phenylamino)-, [1,8-dioxo-8-(phenylamino)octyl]azanyl ester
C28H37N3O5 (495.27330720000003)
9-phenyl-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
C30H35B2NO4 (495.2752050000001)
Tefinostat
C28H37N3O5 (495.27330720000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
N-[(4R,7R,8S)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(5R,6R,9S)-8-(cyclohexylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(5S,6S,9R)-8-(cyclohexylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(5R,6S,9R)-8-(cyclohexylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(5S,6S,9S)-8-(cyclohexylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(5R,6R,9R)-8-(cyclohexylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C25H41N3O5S (495.2766776000001)
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-N-[3-(4-morpholinyl)propyl]-6-oxo-1-propyl-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C27H37N5O4 (495.28454020000004)
N-[(5S,6R,9S)-8-(cyclohexylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(4S,7R,8R)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(4S,7S,8R)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(4R,7S,8R)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(5S,6R,9R)-8-(cyclohexylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(4S,7S,8S)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(4R,7R,8R)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(4R,7S,8S)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
N-[(4S,7R,8S)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C25H41N3O5S (495.2766776000001)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N-[3-(4-morpholinyl)propyl]-6-oxo-1-propyl-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C27H37N5O4 (495.28454020000004)
Antibiotic JI-20B
C20H41N5O9 (495.2904136000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
2-methoxyacetic acid [2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] ester
11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
C26H41NO8 (495.28320260000004)
aconitum kirinense alkaloid
C26H41NO8 (495.28320260000004)
{"Ingredient_id": "HBIN014585","Ingredient_name": "aconitum kirinense alkaloid","Alias": "NA","Ingredient_formula": "C26H41NO8","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7188","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,2r,3r,4r,5r,6s,8r,9r,10r,13r,16s,17s,18s)-11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
C26H41NO8 (495.28320260000004)
{11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl acetate
C26H41NO8 (495.28320260000004)
[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl acetate
C26H41NO8 (495.28320260000004)
(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
C26H41NO8 (495.28320260000004)
(1r,2r,3r,4r,5r,6r,8r,9r,10r,13r,16s,17s,18s)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
C26H41NO8 (495.28320260000004)
(2s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}-3-methyl-n-[(2s)-1-oxo-3-phenylpropan-2-yl]butanimidic acid
C28H37N3O5 (495.27330720000003)
14-ethyl-4,6,19-trimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane-2,3-diol
C26H41NO8 (495.28320260000004)
2-({1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene}amino)-3-methyl-n-(1-oxo-3-phenylpropan-2-yl)butanimidic acid
C28H37N3O5 (495.27330720000003)
11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
C26H41NO8 (495.28320260000004)
11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
C26H41NO8 (495.28320260000004)
(1s,2r,3r,4s,5r,6s,8r,9s,10r,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
C26H41NO8 (495.28320260000004)
(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18r)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
C26H41NO8 (495.28320260000004)
(2s,3s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}-n-[(2s)-1-hydroxy-4-(methylsulfanyl)butan-2-yl]-3-methylpentanimidic acid
C25H41N3O5S (495.2766776000001)
(1s,2r,3r,4r,5r,6s,8r,9s,10s,13s,16r,17r,18r)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
C26H41NO8 (495.28320260000004)
(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
C26H41NO8 (495.28320260000004)
2-({1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene}amino)-n-[1-hydroxy-4-(methylsulfanyl)butan-2-yl]-3-methylpentanimidic acid
C25H41N3O5S (495.2766776000001)
(2s)-2-{[(2r)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}-3-methyl-n-[(2r)-1-oxo-3-phenylpropan-2-yl]butanimidic acid
C28H37N3O5 (495.27330720000003)
[(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl acetate
C26H41NO8 (495.28320260000004)